What Are Anabolic Steroids?

Definition — What Are Anabolic Steroids?

Anabolic-androgenic steroids (AAS) are synthetic derivatives of testosterone — the primary male sex hormone. Every anabolic steroid in existence was developed by modifying the testosterone molecule to enhance either its anabolic (tissue-building) properties, its androgenic (masculinising) properties, or both.

The term "anabolic-androgenic" captures the two core effects:

• Anabolic: promoting muscle growth, nitrogen retention, red blood cell production and bone density — the effects athletes and bodybuilders seek
• Androgenic: driving the development of male sex characteristics — body hair, voice deepening, sebaceous gland activity — effects that vary by compound and individual sensitivity

No anabolic steroid is purely anabolic or purely androgenic. Every compound carries both properties in varying ratios, which is why the anabolic-to-androgenic ratio is one of the key metrics used to compare compounds. Testosterone itself is rated 100:100 — the reference point against which all other AAS are measured.

Brief History of AAS

Testosterone was first isolated in 1935 by three independent research teams — Ernst Laqueur, Leopold Ruzicka and Adolf Butenandt — a discovery significant enough to earn a Nobel Prize. Within years, synthetic testosterone derivatives were being developed with the goal of amplifying its anabolic effects while reducing androgenic activity.

By the 1950s, AAS had entered competitive sport. Soviet weightlifters were reportedly using testosterone at the 1952 Olympics, prompting American physician John Ziegler to develop Dianabol (methandrostenolone) — the first widely used oral anabolic steroid — in collaboration with Ciba Pharmaceuticals in 1958.

Medical applications developed in parallel: AAS became legitimate treatments for muscle-wasting diseases, hypogonadism, delayed puberty and anaemia. The anabolic and androgenic effects that made them useful in medicine also made them attractive to athletes, and non-medical use expanded steadily through the 1960s–1980s.

How Anabolic Steroids Work

AAS exert their effects primarily through androgen receptor (AR) activation. The mechanism is well-established and operates at the level of gene expression:

• Step 1 — Cellular entry: steroid molecules are lipophilic (fat-soluble) and cross cell membranes freely without needing a surface receptor
• Step 2 — Receptor binding: inside the cell, the AAS molecule binds to the androgen receptor in the cytoplasm, forming a steroid-receptor complex
• Step 3 — Nuclear translocation: the complex moves into the cell nucleus and binds to specific DNA sequences called androgen response elements (AREs)
• Step 4 — Gene expression: this binding switches on or amplifies genes responsible for protein synthesis, nitrogen retention, IGF-1 production and erythropoiesis (red blood cell production)
• Step 5 — Protein synthesis: ribosomes produce more structural proteins — particularly actin and myosin — the contractile proteins that make muscle fibres larger and stronger

A secondary mechanism involves glucocorticoid antagonism. At supraphysiological doses, AAS compete with cortisol at glucocorticoid receptors, reducing the catabolic (muscle-breakdown) signalling that cortisol drives — particularly during intense training and caloric deficit.

Types of Anabolic Steroids

AAS are classified by administration route, ester length and structural modification. Understanding these distinctions matters practically — they determine how the compound is used, how long it stays active, and what side effect profile to expect.

By Administration Route

By Anabolic/Androgenic Ratio

By Ester Length

Injectable steroids are bound to ester chains that control how quickly the compound releases into the bloodstream. Longer esters mean slower release, more stable blood levels, and less frequent injections — but longer clearance times before PCT can begin.

Effects — What Steroids Actually Do

The effects of AAS are dose-dependent, compound-specific and highly individual. The following represents the well-documented pharmacological effects at performance-enhancement doses:

• Increased muscle protein synthesis: the primary anabolic driver — more protein is laid down in muscle tissue per training stimulus than is possible naturally
• Enhanced nitrogen retention: muscle tissue stays in positive nitrogen balance — a prerequisite for anabolism; AAS users maintain this state even during caloric restriction
• Reduced recovery time: damaged muscle fibres repair faster, allowing higher training frequency and volume without overtraining
• Increased red blood cell production: particularly with testosterone and Nandrolone — more RBCs means more oxygen delivery to working muscle, enhancing endurance and work capacity
• IGF-1 upregulation: AAS stimulate hepatic IGF-1 production — a potent anabolic hormone that acts synergistically with androgens to drive muscle and connective tissue growth
• Anti-catabolic effect: cortisol competition at glucocorticoid receptors reduces muscle breakdown during training and diet — particularly valuable in cutting phases
• Increased bone mineral density: relevant in medical contexts; at bodybuilding doses this contributes to structural strength and injury resistance

Side Effects and Health Risks

AAS carry real health risks that scale with dose, duration, compound choice and individual genetics. Understanding these is not optional — it is part of responsible use.

Hormonal Suppression

All AAS suppress endogenous testosterone production via HPG axis feedback. The testes stop producing testosterone in response to exogenous androgens. This is universal — no compound avoids it. Recovery requires Post Cycle Therapy with Nolvadex or Clomid. Without PCT, recovery can take 6–18 months and in some cases is incomplete.

Cardiovascular Effects

The cardiovascular risk profile of AAS is the most clinically significant concern at bodybuilding doses:

• Lipid dysregulation: AAS reduce HDL (good cholesterol) and raise LDL — the magnitude varies by compound; oral 17α-alkylated steroids produce the most adverse lipid changes
• Left ventricular hypertrophy: prolonged AAS use causes pathological cardiac muscle thickening — distinct from exercise-induced hypertrophy and associated with arrhythmia risk
• Elevated blood pressure: driven by increased RBC count (haematocrit), water retention and direct vascular effects
• Increased clotting risk: some AAS increase platelet aggregation and coagulation factors

Hepatotoxicity

Oral 17α-alkylated steroids (Dianabol, Anavar, Winstrol) are processed by the liver and can cause enzyme elevation, peliosis hepatis and in severe cases liver tumours with prolonged use. Injectable steroids do not carry meaningful hepatotoxicity. Liver support compounds and limiting oral steroid duration to 4–6 weeks are standard harm-reduction practices.

Androgenic Side Effects

• Acne: driven by sebaceous gland stimulation — severity is largely genetic and compound-dependent
• Male pattern baldness acceleration: DHT-derived compounds are most problematic for genetically predisposed individuals
• Virilisation in women: voice deepening, clitoral enlargement and body hair changes — some changes are irreversible

Psychological Effects

At therapeutic doses the psychological effects of testosterone are generally positive — improved mood, motivation and libido. At supraphysiological doses and with highly androgenic compounds (particularly Trenbolone), mood instability, irritability and aggression are documented. Withdrawal from AAS produces a distinct depressive syndrome driven by hypogonadism — the primary reason PCT matters beyond just physical recovery.

Anabolic Steroids vs Corticosteroids

One of the most common points of confusion is the difference between anabolic steroids and corticosteroids. They share the four-ring steroid backbone but are otherwise entirely different compounds with opposite effects on muscle tissue:

When a doctor prescribes "steroids" for inflammation, they mean corticosteroids — not AAS. The two classes are pharmacologically unrelated in terms of their therapeutic effects.

Anabolic Steroids vs Peptides

As peptides have grown in mainstream awareness, the comparison to AAS comes up frequently. The distinction matters for choosing the right tool for specific goals:

For a detailed breakdown see our full guide: Peptides vs Steroids — full comparison. Both categories are available at Steroid Warehouse Peptides.

Medical Uses of Anabolic Steroids

AAS have well-established, FDA-approved medical applications that predate their use in sport by decades:

• Hypogonadism: testosterone replacement therapy (TRT) is the primary treatment for men with clinically low testosterone — a condition affecting millions of men globally
• Delayed puberty: short-course testosterone therapy initiates puberty in adolescent males with idiopathic delay
• Muscle-wasting diseases: AAS are prescribed for HIV/AIDS-associated wasting, cancer cachexia and severe burns to preserve or restore lean mass
• Anaemia: Nandrolone and oxymetholone are used to stimulate red blood cell production in aplastic anaemia and similar conditions
• Osteoporosis: some AAS increase bone mineral density and have been studied as treatments for osteoporosis, particularly in older men
• Gender-affirming care: testosterone is used in transgender male hormone therapy

The medical context is important for understanding AAS: these are not exclusively recreational drugs. They are pharmaceutical compounds with legitimate clinical applications, prescribed by physicians under medical supervision globally every day.

Frequently Asked Questions